Ashley Cordova - 31 Oct 2023 Form 4 Insider Report for NovoCure Ltd (NVCR)

Role
Chief Financial Officer
Signature
Ovie Onobrakpeya, as attorney in fact for Cordova, Ashley
Issuer symbol
NVCR
Transactions as of
31 Oct 2023
Net transactions value
+$172,453
Form type
4
Filing time
02 Nov 2023, 16:20:51 UTC
Previous filing
05 Sep 2023
Next filing
29 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVCR Ordinary Shares Options Exercise $86,649 +7,561 +7.6% $11.46 107,211 31 Oct 2023 Direct
transaction NVCR Ordinary Shares Options Exercise $28,371 +2,480 +2.3% $11.44 109,691 31 Oct 2023 Direct
transaction NVCR Ordinary Shares Options Exercise $55,427 +7,752 +7.1% $7.15 117,443 31 Oct 2023 Direct
transaction NVCR Ordinary Shares Options Exercise $2,006 +175 +0.15% $11.46 117,618 02 Nov 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NVCR Stock Option (Right to Buy) Options Exercise $0 -7,561 -98% $0.000000 175 31 Oct 2023 Ordinary Shares 7,561 $11.46 Direct F1
transaction NVCR Stock Option (Right to Buy) Options Exercise $0 -2,480 -100% $0.000000* 0 31 Oct 2023 Ordinary Shares 2,480 $11.44 Direct
transaction NVCR Stock Option (Right to Buy) Options Exercise $0 -7,752 -100% $0.000000* 0 31 Oct 2023 Ordinary Shares 7,752 $7.15 Direct F2
transaction NVCR Stock Option (Right to Buy) Options Exercise $0 -175 -100% $0.000000* 0 02 Nov 2023 Ordinary Shares 175 $11.46 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Vests 2,686 share(s) on 24-Feb-2019, 6,250 share(s) on 24-Feb-2020
F2 Vests 2 share(s) on 22-Feb-2018, 9,750 share(s) on 22-Feb-2021